Wuhan BGI Medical Laboratory Co., Ltd.

Since its establishment in 1999, BGI has adhered to the principle of "using tasks to drive disciplines, industries, and talent development." It has successively completed the "Chinese portion" of the International Human Genome Project, the International HapMap Project, the Rice Genome Project, the Silkworm Genome Project, the Chicken Genome Project, anti-SARS research, the "Yanhuang No. 1" (100%), giant panda, and many other internationally advanced genomic research projects.
Wuhan BGI upholds its industrial ideals, inherits the philosophy of its headquarters, and develops regional characteristics. With scientific development and industry as the priority, it is forging a brand-new genetic industry path in the era of the bioeconomy! A first-class enterprise needs more diversified talent, and we are willing to provide society with a variety of job opportunities; Wuhan BGI sincerely welcomes outstanding talent to join us and work together to create a new world in the bio-high-tech industry.